(Q36622330)

15 August 2017

Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas (English)

1 reference

15 August 2017

phase II clinical trial

0 references

1

Margaret von Mehren

1 reference

15 August 2017

Cathryn Rankin

2

1 reference

15 August 2017

John R Goldblum

3

1 reference

15 August 2017

George D Demetri

4

1 reference

15 August 2017

Vivien Bramwell

5

1 reference

15 August 2017

Christopher W Ryan

6

1 reference

15 August 2017

Ernest Borden

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

15 August 2017

1 reference

15 August 2017

118

1 reference

15 August 2017

3

1 reference

15 August 2017

770-776

1 reference

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Response to sunitinib malate in advanced alveolar soft part sarcoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Sorafenib in advanced clear-cell renal-cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Angiogenesis and antiangiogenic approaches to sarcomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Sorafenib is active on lung metastases from synovial sarcoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

A Kaposi's sarcoma complete clinical response after sorafenib administration

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3576704

Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26334

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

21 January 2018

1 reference

12 December 2020

In situ distribution of the beta-subunit of platelet-derived growth factor receptor in nonneoplastic tissue and in soft tissue tumors

1 reference

12 December 2020

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma

1 reference

12 December 2020

Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.26334

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

21751200

1 reference